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sclerosis and mesangial proliferation in frequently relapsing/
steroid-dependent nephrotic syndrome.
Thus, it is not so clear that steroid resistance among
children with initially steroid-responsive nephrotic syndrome
is more common now compared to 20–30 years ago.
Furthermore, although the prevalence of lesions other than
minimal change among all children with nephrotic syndrome
or with initially steroid-resistant nephrotic syndrome may be
increasing,4 it is also not clear that lesions other than
minimal change disease in those with steroid responsiveness
and subsequent development of steroid resistance have
become more common.
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To the Editor: Cebotaru et al.1 have shown that a high citrate
diet prevents the tubulointerstitial damage in a mouse model
of Dent’s disease. The implicit hypothesis was that the
increase in citraturia prevents calcium crystallization and the
secondary renal damage. The results are very interesting
particularly in reference to an orphan disease as Dent’s
disease. However, an alternative explanation of these findings
may be proposed. The problem is whether the knockout
animals have a metabolic acidosis. I think they have it, as
suggested by the following observations. As dietary citrate
ameliorates metabolic acidosis, the intracellular (including
tubular cell) acidosis should also improve. The latter would
translate in an increased citraturia, which indeed is observed
in the knockout animals although not statistically significant.
Correction by citrate of metabolic acidosis in the mutated
animals would also explain why the urinary pH is lower than
in the wild-type animals. Interestingly, these findings may
also be explained from a different standpoint. Actually,
Cheema-Dhadli et al.2 have shown that the earlier response
to an alkali load in normal rats is a decline in the excretion
of NH4
þ followed by an increase in the excretion of citrate.
If the knockout animals have metabolic acidosis, an increased
ammoniogenesis is expected, which might be one of the
triggers of the renal damage.3 Thus, reduction of renal
ammoniogenesis by the alkaline (citrate) load could prevent
chronic tubulointerstitial injuries as shown by the Hostetters3
after their landmark studies on the pathogenic role of
ammonia in the progression of chronic nephropathies.
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The authors1 suggest another interpretation of our data,
the major fact being that there is an acidic environment
in the ClCn-5 knockout (ko) mouse kidney. We do agree
with the authors that as renal failure progresses, it is likely
that the ClCn-5 ko mice have metabolic acidosis, but we
do not think younger ko mice without renal failure have
significant metabolic acidosis based on the following
information: (1) The wild-type and ClCn-5 ko mice show
no significant difference in citrate excretion on either diet.
(2) On a zero citrate diet, the wild-type and ClCn-5 ko
mice have no difference in urinary pH (pH of 5.94 and
6.03, respectively). (3) The wild-type mice have an alkaline
pH on the high citrate diet (pH 6.79) compared to the low
citrate diet, but the ClCn-5 ko mice do not have an
alkalization of urine pH (pH 6.01) compared to a no citrate
diet (pH 6.03). (4) On a high citrate diet, there is not a
difference in blood pH or blood gases for wild-type and
ClCn-5 ko mice (unpublished data). From these data, we
conclude that the delay in renal failure in ClCn-5 ko mice
on a high citrate diet is not caused by the amelioration
of the acidic environment of the kidney, but from the
addition of citrate to the diet.
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